Litcius/Paper detail

Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment

Xiujuan Han, Chunai Gong, Qingru Yang, Kaile Zheng, Zhuo Wang, Wei Zhang

2024International Journal of Nanomedicine88 citationsDOIOpen Access PDF

Abstract

With the development of nanotechnology, nanoparticles (NPs) have shown broad prospects as drug delivery vehicles. However, they exhibit certain limitations, including low biocompatibility, poor physiological stability, rapid clearance from the body, and nonspecific targeting, which have hampered their clinical application. Therefore, the development of novel drug delivery systems with improved biocompatibility and high target specificity remains a major challenge. In recent years, biofilm mediated biomimetic nano-drug delivery system (BNDDS) has become a research hotspot focus in the field of life sciences. This new biomimetic platform uses bio-nanotechnology to encapsulate synthetic NPswithin biomimetic membrane, organically integrating the low immunogenicity, low toxicity, high tumor targeting, good biocompatibility of the biofilm with the adjustability and versatility of the nanocarrier, and shows promising applications in the field of precision tumor therapy. In this review, we systematically summarize the new progress in BNDDS used for optimizing drug delivery, providing a theoretical reference for optimizing drug delivery and designing safe and efficient treatment strategies to improve tumor treatment outcomes.

Topics & Concepts

NanocarriersBiocompatibilityDrug deliveryNanotechnologyMaterials scienceTargeted drug deliveryMetallurgyNanoplatforms for cancer theranosticsNanoparticle-Based Drug DeliveryRNA Interference and Gene Delivery
Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment | Litcius